Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1888709

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1888709

Neuroprosthetics Market Size, Share & Trends Analysis Report By Type, By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Neuroprosthetics Market Summary

The global neuroprosthetics market size was estimated at USD 14.62 billion in 2024 and is projected to reach USD 47.0 billion by 2033, growing at a CAGR of 13.69% from 2025 to 2033. The market is driven by the increasing prevalence of neurological, cardiac, and kidney disorders, as well as ongoing advancements in medical technology.

In addition, expanded research efforts and a greater focus on industry growth are anticipated to support the market in the coming years. The burden of neurological disorders such as Parkinson's disease, epilepsy, Alzheimer's disease, and depression is increasing significantly, which is anticipated to propel the demand for neuroprosthetic devices. According to the WHO data published in February 2024, approximately 50 million people worldwide are living with epilepsy. Furthermore, the burden of neurological disorders remains significant across various demographic groups, contributing to the rising demand for neuroprosthetic devices. According to the CDC, approximately 2.9 million U.S. adults aged 18 and older reported having active epilepsy during 2021 and 2022.

Furthermore, the increasing prevalence of physiological disorders, particularly those affecting the auditory, ophthalmic, cardiac, and renal systems, is expected to drive market growth. According to WHO data published in February 2025, around 2.5 billion people may experience some extent of hearing loss by 2050, with over 700 million requiring hearing rehabilitation.

Currently, over 430 million individuals, representing more than 5% of the global population, including 34 million children, require rehabilitation for hearing loss. This number is projected to exceed 700 million, or about 1 in 10 people, by 2050. Around 80% of those with hearing loss live in low- and middle-income countries, and prevalence rises with age, affecting over 25% of adults above 60. This increasing global burden of auditory disorders is expected to drive demand for cochlear implants and support market expansion during the forecast period.

Global Neuroprosthetics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neuroprosthetics market report based on type, technology, application, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Motor Prosthetics
  • Cochlear Implants
  • Cognitive Prosthetics
  • Retinal Implants
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Deep Brain Stimulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Spinal Cord Stimulation (SCS)
  • Sacral Nerve Stimulation (SNS)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Motor Neuron Disorders
    • Parkinson's Disease
    • Epilepsy
  • Physiological Disorders
    • Auditory Disorders
    • Opthalmic Disorders
    • Cardiac Disorders
    • Kidney Disorders
  • Cognitive Disorders
    • Alzheimer's Disease
    • Severe Depression
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-891-6

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Applications
    • 1.2.3. Technology
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neuroprosthetics Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Target Diseases
      • 3.2.1.2. Technological Advancements In Neuroprosthetics
      • 3.2.1.3. Rising Number of Awareness Initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Number of Clinical Trials
      • 3.2.3.2. Launches Of Novel Products
      • 3.2.3.3. Increasing Research & Development Activities
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Shortage of Skilled Professionals
      • 3.2.4.2. Potential Complications & Risks Associated with Neuroprosthetics
  • 3.3. Neuroprosthetics Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neuroprosthetics Market: Segment Analysis, By Type, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2033
  • 4.3. Global Neuroprosthetics Market, by Type, 2021 to 2033
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 4.4.1. Motor Prosthetics
      • 4.4.1.1. Motor prosthetics devices market, 2021 - 2033 (USD Million)
    • 4.4.2. Cochlear Implants
      • 4.4.2.1. Cochlear implants market, 2021 - 2033 (USD Million)
    • 4.4.3. Cognitive Prosthetics
      • 4.4.3.1. Cognitive prosthetics market, 2021 - 2033 (USD Million)
    • 4.4.4. Retinal Implants
      • 4.4.4.1. Retinal implants market, 2021 - 2033 (USD Million)

Chapter 5. Neuroprosthetics Market: Segment Analysis, By Applications, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Applications Market Share Analysis, 2024 & 2033
  • 5.3. Global Neuroprosthetics Market, by Applications, 2021 to 2033
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 5.4.1. Motor Neuron Disorders
      • 5.4.1.1. Motor neuron disorders market, 2021 - 2033 (USD Million)
      • 5.4.1.2. Parkinson's Disease
        • 5.4.1.2.1. Parkinson's disease market, 2021 - 2033 (USD Million)
      • 5.4.1.3. Epilepsy
        • 5.4.1.3.1. Epilepsy market, 2021 - 2033 (USD Million)
    • 5.4.2. Physiological Disorders
      • 5.4.2.1. Physiological disorders market, 2021 - 2033 (USD Million)
      • 5.4.2.2. Auditory Disorders
        • 5.4.2.2.1. Auditory disorders market, 2021 - 2033 (USD Million)
      • 5.4.2.3. Ophthalmic Disorders
        • 5.4.2.3.1. Ophthalmic disorders market, 2021 - 2033 (USD Million)
      • 5.4.2.4. Cardiac Disorders
        • 5.4.2.4.1. Cardiac disorders market, 2021 - 2033 (USD Million)
      • 5.4.2.5. Kidney Disorders
        • 5.4.2.5.1. Kidney disorders market, 2021 - 2033 (USD Million)
    • 5.4.3. Cognitive Disorders
      • 5.4.3.1. Cognitive disorders market, 2021 - 2033 (USD Million)
      • 5.4.3.2. Alzheimer's Disease
        • 5.4.3.2.1. Alzheimer's disease market, 2021 - 2033 (USD Million)
      • 5.4.3.3. Severe Depression
        • 5.4.3.3.1. Severe depression market, 2021 - 2033 (USD Million)

Chapter 6. Neuroprosthetics Market: Segment Analysis, By Technology, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Technology Market Share Analysis, 2024 & 2033
  • 6.3. Global Neuroprosthetics Market, by Technology, 2021 to 2033
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
    • 6.4.1. Deep Brain Stimulation
      • 6.4.1.1. Deep brain stimulation market, 2021 - 2033 (USD Million)
    • 6.4.2. Vagus Nerve Stimulation
      • 6.4.2.1. Vagus nerve stimulation market, 2021 - 2033 (USD Million)
    • 6.4.3. Spinal Cord Stimulation
      • 6.4.3.1. Spinal cord stimulation market, 2021 - 2033 (USD Million)
    • 6.4.4. Sacral Nerve Stimulation
      • 6.4.4.1. Sacral nerve stimulation market, 2021 - 2033 (USD Million)

Chapter 7. Neuroprosthetics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Global Key company market share analysis, 2024
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. LivaNova PLC
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Cochlear Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Nevro Corp
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Sonova
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Science Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Advanced Bionics AG
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. MED-EL Medical Electronics
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
  • 8.4. Heat Map Analysis/ Company Market Position Analysis
  • 8.5. Estimated Company Market Share Analysis, 2024
  • 8.6. List of Other Key Market Players
Show more
Product Code: 978-1-68038-891-6

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America neuroprosthetics market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 5 North America neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 7 U.S. neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 8 U.S. neuroprosthetics, by application, 2021 - 2033 (USD Million)
  • Table 9 U.S. neuroprosthetics, by technology, 2021 - 2033 (USD Million)
  • Table 10 Canada neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 11 Canada neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 12 Canada neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 13 Mexico neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 14 Mexico neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 15 Mexico neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 16 Europe neuroprosthetics market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 18 Europe neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 19 Europe neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 20 UK neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 21 UK neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 22 UK neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 23 Germany neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 24 Germany neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 25 Germany neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 26 France neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 27 France neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 28 France neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 29 Italy neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 30 Italy neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 31 Italy neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 32 Spain neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 33 Spain neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 34 Spain neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 35 Norway neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 36 Norway neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 37 Norway neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 38 Sweden neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 39 Sweden neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 40 Sweden neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Denmark neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 42 Denmark neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 43 Denmark neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific neuroprosthetics market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 48 China neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 49 China neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 50 China neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 51 Japan neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 52 Japan neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 54 India neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 55 India neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 56 India neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 57 Australia neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 58 Australia neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 59 Australia neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 60 South Korea neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 61 South Korea neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 63 Latin America neuroprosthetics market, by country, 2021 - 2033 (USD Million)
  • Table 64 Latin America neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 65 Latin America neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 66 Latin America neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 67 Brazil neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 68 Brazil neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 69 Brazil neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 70 Argentina neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 71 Argentina neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 72 Argentina neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Middle East & Africa neuroprosthetics market, by country, 2021 - 2033 (USD Million)
  • Table 74 Middle East & Africa neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 75 Middle East & Africa neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 77 South Africa neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 78 South Africa neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 79 South Africa neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 80 Saudi Arabia neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 81 Saudi Arabia neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 83 UAE neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 84 UAE neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 85 UAE neuroprosthetics market, by technology, 2021 - 2033 (USD Million)
  • Table 86 Kuwait neuroprosthetics market, by type, 2021 - 2033 (USD Million)
  • Table 87 Kuwait neuroprosthetics market, by application, 2021 - 2033 (USD Million)
  • Table 88 Kuwait neuroprosthetics market, by technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Index of Figures
  • Fig. 2 Neuroprosthetics market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement
  • Fig. 5 Primary research pattern
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modeling for market share assessment
  • Fig. 9 Market formulation & validation
  • Fig. 10 Market outlook (2024)
  • Fig. 11 Segment Outlook
  • Fig. 12 Strategy framework
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Neuroprosthetics market: Type movement analysis
  • Fig. 19 Neuroprosthetics market type outlook: Key takeaways
  • Fig. 20 Motor prosthetics market, 2021 - 2033 (USD Million)
  • Fig. 21 Cochlear implants market, 2021 - 2033 (USD Million)
  • Fig. 22 Cognitive prosthetics market, 2021 - 2033 (USD Million)
  • Fig. 23 Retinal implants market, 2021 - 2033 (USD Million)
  • Fig. 24 Neuroprosthetics market: Technology movement analysis
  • Fig. 25 Neuroprosthetics market Technology outlook: Key takeaways
  • Fig. 26 Deep brain stimulation market, 2021 - 2033 (USD Million)
  • Fig. 27 Vagus nerve stimulation market, 2021 - 2033 (USD Million)
  • Fig. 28 Spinal cord stimulation market, 2021 - 2033 (USD Million)
  • Fig. 29 Sacral nerve stimulation market, 2021 - 2033 (USD Million)
  • Fig. 30 Neuroprosthetics market: Application movement analysis
  • Fig. 31 Neuroprosthetics market Applications outlook: Key takeaways
  • Fig. 32 Motor neuron disorders market, 2021 - 2033 (USD Million)
  • Fig. 33 Parkinson's disease market, 2021 - 2033 (USD Million)
  • Fig. 34 Epilepsy market, 2021 - 2033 (USD Million)
  • Fig. 35 Physiological disorders market, 2021 - 2033 (USD Million)
  • Fig. 36 Auditory disorders market, 2021 - 2033 (USD Million)
  • Fig. 37 Ophthalmic disorders market, 2021 - 2033 (USD Million)
  • Fig. 38 Cardiac disorders market, 2021 - 2033 (USD Million)
  • Fig. 39 Kidney disorders market, 2021 - 2033 (USD Million)
  • Fig. 40 Cognitive disorders market, 2021 - 2033 (USD Million)
  • Fig. 41 Alzheimer's disease market, 2021 - 2033 (USD Million)
  • Fig. 42 Severe depression market, 2021 - 2033 (USD Million)
  • Fig. 43 Regional outlook, 2024 & 2033
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 47 Canada neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 48 Europe neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 49 UK. neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 50 Germany neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 51 France neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 52 Italy neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 54 Norway neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 59 China neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 60 India neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 61 Australia neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 66 Mexico neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 68 MEA neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE neuroprosthetics market, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait neuroprosthetics market, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!